Orbera™ Managed Weight Loss
- Safe and effective weight loss solution
- Over 220,000 placements worldwide
- Now FDA approved
- Comprehensive two-part program designed to provide effective, motivating results that you can see. With Orbera™ patients on average lose 3.1 times the weight they would with diet and exercise alone.
- Starts with a soft balloon placed in your stomach for six months to reinforce proper portion control.
- The Orbera™ balloon takes up space in your stomach and helps you eat smaller meals.
- Balloon is temporary and placed in your stomach for six months without surgery or any incisions.
- Patients will receive coaching from our Health and Wellness Coordinator and their Physician after the balloon is placed and coaching will continue for six months after the balloon is removed.
- Orbera™ is a non-surgical procedure under a mild sedative. The thin and deflated Orbera™ balloon is placed into the stomach. It is then filled with saline until it’s about the size of a grapefruit. The procedure typically takes about 20-30 minutes so you can go home the very same day.
- At six months, the balloon is removed through another non-surgical procedure under a mild sedative.
- The weight loss with Orbera™ is rapid, with the majority of weight loss typically occurring in the first three months of treatment.
- On average patients lost 3.1 times the weight loss of diet and exercise alone.
- The adjustments to your eating habits and your continued efforts to stay active will greatly influence your results.
- Be an adult over the age of 18.
- Have a Body Mass Index (BMI) of 30 to 40.
- Be willing to participate in a medically supervised program.
- After six months with the Orbera™ two-part program, people lost an average 3.1x the weight patients lost with diet & exercise alone.
- Orbera™ has been helping thousands of people lose weight for over 20 years.
- More than 220,000 Orbera™ balloons have been distributed worldwide in over 80 countries. With the FDA approval of Orbera™, patients now have a safe and effective treatment option.